可注射微退火多孔支架用于关节软骨再生
本研究在大鼠膝关节骨软骨缺损模型中评估可注射微孔退火颗粒(MAP)水凝胶支架的可行性,并与生理盐水对照比较。组织学与免疫组化显示MAP凝胶可在缺损内退火并稳定整合,维持缺损尺寸、促进组织长入和糖胺聚糖产生,无显著炎症反应,对照则为紊乱瘢痕组织。
要点
- MAP凝胶可注射、流动、光退火后稳定填充骨软骨缺损。
- MAP组维持缺损尺寸并见组织长入与糖胺聚糖增加,无显著炎症。
- 流动特性支持关节镜下微创应用,未来可化学机械生物改性。
核心结论
- 可注射流动MAP凝胶支架成功递送至大鼠膝骨软骨缺损,退火后稳定整合于愈合创面。
- MAP凝胶填充缺损、维持缺损尺寸并提供连续光滑表面,提示可为组织长入提供稳定支架。
研究设计与样本
- 大鼠膝关节骨软骨缺损模型,设生理盐水对照与MAP凝胶治疗两组。
- 注射后行光退火,术后2、4、8周进行定性组织学与免疫组化分析。
主要发现
- MAP凝胶在各时间点成功退火并留存于骨软骨缺损内。
- MAP组维持骨软骨缺损尺寸,见组织长入和糖胺聚糖产生增加。
- 对照缺损表现为紊乱瘢痕组织。
- 组织学未见对MAP凝胶的显著炎症反应。
临床怎么用
- MAP凝胶流动可注射,支持关节镜下微创递送,例如用于腕关节炎管理。
局限性
- 原文为动物模型定性组织学与免疫组化分析,未报告定量再生证据。
- 未来需化学、机械和生物学凝胶改性以改善软骨再生的客观证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study is to assess the feasibility of a novel microporous annealed particle (MAP) scaffolding hydrogel to enable both articular cartilage and subchondral bone biointegration and chondrocyte regeneration in a rat knee osteochondral defect model. METHODS: An injectable, microporous scaffold was engineered and modified to match the mechanical properties of articular cartilage. Two experimental groups were utilized-negative saline control and MAP gel treatment group. Saline and MAP gel were injected into osteochondral defects created in the knees of Sprague-Dawley rats. Photo-annealing of the MAP gel was performed. Qualitative histologic and immunohistochemical analysis was performed of the treated defects at 2, 4, and 8 weeks postsurgery. RESULTS: The injectable MAP gel successfully annealed and was sustained within the osteochondral defect at each timepoint. Treatment with MAP gel resulted in maintained size of the osteochondral defect with evidence of tissue ingrowth and increased glycosaminoglycan production, whereas the control defects presented with evidence of disorganized scar tissue. Additionally, there was no significant inflammatory response to the MAP gel noted on histology. CONCLUSIONS: We have demonstrated the successful delivery of an injectable, flowable MAP gel scaffold into a rat knee osteochondral defect with subsequent annealing and stable integration into the healing wound. The flowable nature of this scaffold allows for minimally invasive application, for example, via an arthroscopic approach for management of wrist arthritis. The MAP gel was noted to fill the osteochondral defect and maintain the defect dimensions and provide a continuous and smooth surface for cartilage regeneration, suggesting its ability to provide a stable scaffold for tissue ingrowth. Future chemical, mechanical, and biological gel modifications may improve objective evidence of cartilage regeneration.
引用
- Schaeffer C, Pfaff BN, Cornell NJ, et al. Injectable Microannealed Porous Scaffold for Articular Cartilage Regeneration. Ann Plast Surg. 2020. PMID: 32032122. doi:10.1097/SAP.0000000000002271
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。